))
Episode 8: The Nitrosamine Crisis: Controlling Risk by Leveraging MLCM Principles – Part 1
Manage episode 311698774 series 3168969
Content provided by Larry Hines and Waters Corporation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Larry Hines and Waters Corporation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In part one of a 3-part series on the Nitrosamine crisis, Dr. Andrew Teasdale of AstraZeneca discusses regulatory expectations, reporting requirements, and minimizing risk relative to solvent contamination.
15 episodes
Share
